Life Science
Builders

These Life Science Builders agree that society's payments for branded drugs must be a finite mortgage, oppose the rent extraction that is on the rise in the drug industry today, and stand with No Patient Left Behind in calling on Congress to pass Contractual Genericization.

Become an NPLB Life Science Builder

Contact us here

Innovators

Adam Rosenberg
Neurological Disorders
Adrian Rawcliffe
Cancer
Andrew Levin MD PhD
Pain
Aoife Brennan MB CHB
Rare Diseases
Axel Bolte
Rare Diseases
Barry Greene
Genetic Disorders
Bharatt Chowrira PhD
Immune Disorders
Bill Newell
Cancer
Burt Adelman MD
Atherosclerosis
Cedric Francois MD PhD
Blindness
Chandra Vargeese PhD
Neurological Disorders
Christian Henry
Genetic Diseases
Dan Grau
Neurological Disorders
Daphne Zohar
Immune Disorders
Dave Van Meter
Glaucoma
David Epstein
Cancer
David Katz PhD
Cushing's Syndrome
David-Alexandre Gros MD
Autoimmune Disorders
Doug Fambrough PhD
Rare Diseases
Eamon Brady
Heart Failure
Frank Watanabe
Psoriasis
Gabriel Otte
Colorectal Cancer
Gil Beyen
Cancer
Gino Santini
Chronic Pain
Glenn Batchelder
Parkinson's Disease
Greg Mann
Cancer
Greg Weaver
Depression
Gregory Verdine PhD
Cancer
Gustav Christensen
Hereditary Angioedema
Ilan Ganot
Duchenne Muscular Dystrophy
Jeffrey Goldberg
Immuno-oncology
Jeremy Levin DPhil MB CHB
Neurological Dis
Jim Greenwood
Industry Leader
John Kollins
Migraine
John Maraganore PhD
Genetic Disorders
John Tucker
Heart Failure
Jose Juves
Neurological Disorders
Keith Murphy
Organ Damage Repair
Ken Rhodes PhD
Neurological Disorders
Ken Takanashi
Migraine
Kevin Buchi
Rare Diseases
Kurt Graves
Type 2 Diabetes
Laura Shawver PhD
Cancer
Laurie Keating
Rare Diseases
Marcos Milla PhD,
Autoimmune Disorders
Mark Corrigan MD
Charcot Marie Tooth
Mark Velleca MD PhD
Cancer
Marsha Fanucci
Rare Diseases
Matthew Kane
Cancer
Michael Ehlers MD PhD,
Rare Diseases
Michael Gilman PhD
Cancer
Michael Hayden MD PhD
Neuro/Psychiatric Diso
Michael Narachi
Neurological Disorders
Michael Panzara MD
Neurological Disorders
Michael Weiss
Lymphoma
Mike Grey
Rare Diseases
Milind Deshpande PhD
Infectious Diseases
Nancy Thornberry MD
Obesity
Pablo Cagnoni MD
Cancer
Patricia Fraser MD
Lupus
Paul Bolno MD
Neurological Disorders
Paul Hastings
Cancer
Perry Karsen
Genetic Disorders
Peter Lanciano
Cancer
Peter Thompson MD
Cancer
Peter Wirth
Cancer
Pratik Shah PhD
Neurological Disorders
Rachel King
Leukemia
Rahul Ballal PhD
Sickle Cell Anemia
Rahul Kakkar MD
Autoimmune Disorders
Ramin Farzaneh-Far MD
Complement Disorders
Rick Klausner MD
Cancer
Riley Ennis
Colorectal Cancer
Robert Gould PhD
Genetic Disorders
Ron Cohen MD
Parkinson's Disease
Ruth Thieroff-Ekerdt MD
Neurological Disorders
Scott Rakestraw PhD
Neurological Disorders
Stephen Hoffman MD PhD
Rare Diseases
Steve Lufkin
Infectious Diseases
Steve Sherwin MD
Cancer
Ted Love MD
Sickle Cell Anemia
Tim Noyes
Kidney Disease
Tim Springer PhD
Ulcerative Colitis
Troy Ignelzi
Neuropsychiatry
Vicki Sato PhD
Infectious Diseases
Vikram Sheel Kumar MD
Cancer
Wendell Wierenga PhD
Endocrine Disorders
Wendye Robbins MD
Fibrotic Diseases
Ypke Van Oosterhout PhD
Immune Disorders
Yvonne Greenstreet MBChB
Genetic Disorders

Biotech investors

Aaron Davis
Adam Mikkelson
Alex Karnal
Andreas Wicki PhD
Andy Acker
Andy Schwab
Arjun Goyal MD
Art Pappas
Bob Deresiewicz MD
Brook Byers
Bruce Booth DPhil
Christoph Westphal MD PhD
Clay Thorp
Corey Goodman PhD
DA Wallach
Dan Lyons PhD
David Beier
David Goeddel PhD
David Socks
Gaurav Aggarwal MD
Graham Walmsley MD PhD
Howie Furst MD
Jack Nielsen
Jakob Loven PhD
Jamie Topper MD
Janice Bourque
Janis Naeve PhD
Jay Lichter PhD
Jean-Francois Formela MD
Jon Edwards PhD
Jonathan Leff
Josh Resnick MD
Martin Heidecker PhD
Matthew Perry
Michelle Dipp MD PhD
Nimish Shah
Nina Kjellson
Otello Stampacchia PhD
Peter Kolchinsky PhD
Pieter Boelhouwer
Rajeev Shah
Rich Aldrich
Rob Hopfner PhD
Rob Perez
Sara Nayeem MD
Scott Gazelle MD PhD
Steve Squinto PhD
Thilo Schroeder PhD
Tim Shannon MD
Walter H. Moos PhD
Wende Hutton

Industry advisors

Bruce Dobbs
Catherine Arnold
Jeffrey Solomon
Jonathan Kfoury
Julia Gaebler PhD
Rick Wiessenstein

Become an NPLB Life Science Builder

Contact us here